Treatment of hyperhidrosis with botulinum toxin

Aesthetic Surgery Journal

Volumn 32, Issue 2, 2012, Pages 238-244

  Doft, Melissa A ^a   Hardy, Krista L ^a   Ascherman, Jeffrey A ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Botox; Cosmetic medicine; Hyperhidrosis

Indexed keywords

BOTULINUM TOXIN A; BOTULINUM TOXIN B;

ARTICLE; AXILLARY HYPERHIDROSIS; DRUG EFFICACY; HUMAN; HYPERHIDROSIS; PALMAR HYPERHIDROSIS; PATIENT SATISFACTION; PLANTAR HYPERHIDROSIS; PREOPERATIVE CARE; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT OUTCOME;

BOTULINUM TOXINS, TYPE A; HUMANS; HYPERHIDROSIS; INJECTIONS; NEUROMUSCULAR AGENTS; PATIENT SATISFACTION; QUALITY OF LIFE; SWEATING; TREATMENT OUTCOME;

EID: 84858250351     PISSN: 1090820X     EISSN: 1527330X     Source Type: Journal    
DOI: 10.1177/1090820X11434506     Document Type: Article

References (42)

1. Strutton DR, Kowalski JW, Glaser DA, Stang PE. US prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis: results from a national survey. J Am Acad Dermatol 2004;51:241-248.
2. Naumann MK, Hamm H, Lowe NJ, on behalf of the Botox Hyperhidrosis Clinical Study Group. Effect of botulinum toxin type A on quality of life measures in patients with excessive axillary sweating: a randomized controlled trial. Br J Dermatol 2002;147:1218-1226. (Pubitemid 36963031)
3. Solish N, Benohanian A, Kowalski J W. Prospective open-label study of botulinum toxin type A in patients with primary axillary hyperhidrosis: effects on functional impairment and quality of life. Dermatol Surg 2005;31:405-413. (Pubitemid 40489300)
4. Swartling C, Naver H, Lindberg M. Botulinum A toxin improves life quality in severe primary focal hyperhidrosis. Eur J Neurol 2001;8:247-252. (Pubitemid 32476623)
5. Campanati A, Penna L, Guzzo T, et al. Quality-of-life assessment in patients with hyperhidrosis before and after treatment with botulinum toxin: results of an openlabel study. Clin Ther 2003;25:298-308. (Pubitemid 36206754)
6. Hornberger J, Grimes K, Naumann M, et al. Multispecialty working group on the recognition, diagnosis, and treatment of primary focal hyperhidrosis: recognition, diagnosis, and treatment of primary focal hyperhidrosis. J Am Acad Dermatol 2004;51:274-286.
7. Flanagan KH, King R, Glaser DA. Botulinum toxin type A versus topical 20% aluminum chloride for the treatment of moderate to severe primary focal axillary hyperhidrosis. J Drugs Dermatol 2008;7:221-227.
8. Woolery-Lloyd H, Valins W. Aluminum chloride hexahydrate in a salicylic acid gel: a novel topical agent for hyperhidrosis with decreased irritation. J Clin Aesthetic Dermatol 2009;2:28-31.
9. Zacherl J, Huber ER, Imhof M, et al. Long-term results of 630 thoracoscopic sympathicotomies for primary hyperhidrosis: the Vienna experience. Eur J Surg Suppl 1998;580:43-46. (Pubitemid 28215267)
10. Lin T, Wang N, Huang L. Pitfalls and complication avoidance associated with transthoracic endoscopic sympathectomy for primary hyperhidrosis (analysis of 2200 cases). Int J Surg Investig 2001;2:377-385.
11. Gossot D, Galetta D, Pascal A, et al. Long-term results of endoscopic thoracic sympathectomy for upper limb hyperhidrosis. Ann Thorac Surg 2003;75:1075-1079. (Pubitemid 36399378)
12. Arneja JS, Hayakawa T E J, Singh GB, et al. Axillary hyperhidrosis: a 5-year review of treatment efficacy and recurrence rates using a new arthroscopic shaver technique. Plast Reconstr Surg 2007;119:562-567. (Pubitemid 46142942)
13. Tung T. Endoscopic shaver with liposuction for treatment of axillary osmidrosis. Ann Plast Surg 2001;46:400-404. (Pubitemid 32319678)
14. Swartling C, Naver H, Pihl-Lundin I, et al. Sweat gland morphology and periglandular innervation in essential palmar hyperhidrosis before and after treatment with intradermal botulinum toxin. J Am Acad Dermatol 2004;54:739-745. (Pubitemid 39516888)
15. Bushara KO, Park DM, Jones JC, et al. Botulinum toxin-a possible new treatment for axillary hyperhidrosis. Clin Exp Dermatol 1996;21:276-278. (Pubitemid 26380193)
16. Glogau RG. Botulinum A neurotoxin for axillary hyperhidrosis: no sweat Botox. Dermatol Surg 1998;24:817-819. (Pubitemid 28405012)
17. Naver H, Swartling C, Aquilonius SM. Palmar and axillary hyperhidrosis treated with botulinum toxin: one-year clinical follow-up. Eur J Neurol 2000;7:55-62. (Pubitemid 32268736)
18. Naumann M, Lowe NJ. Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomized, parallel group, double blind, placebo controlled trial. Br Med J 2001;323:596-599. (Pubitemid 32846124)
19. Odderson IR. Long-term quantitative benefits of botulinum toxin type A in the treatment of axillary hyperhidrosis. Dermatol Surg 2002;28:480-483. (Pubitemid 34686631)
20. Heckmann M, Ceballos-Baumann AO, Plewig G; Hyperhidrosis Study Group. Botulinum toxin A for axillary hyperhidrosis (excessive sweating). N Engl J Med 2001;344:488-493. (Pubitemid 32164900)
21. Lowe NJ, Glaser DE, Eadie N, et al. Botulinum toxin type A in the treatment of primary axillary hyperhidrosis: a 52-week multicenter double-blind, randomized, placebocontrolled study of efficacy and safety. J Am Acad Dermatol 2007;56:604-611. (Pubitemid 46400197)
22. Lowe NJ. The place of botulinum toxin type A in the treatment of focal hyperhidrosis. Br J Dermatol 2004;151:1115-1122. (Pubitemid 40030157)
23. Doft M, Kasten J, Ascherman J. Treatment of axillary hyperhidrosis with botulinum toxin, a single surgeon's experience with 53 consecutive patients. Aesthetic Plastic Surg 2011;35:1079-1086.
24. Atkins JL, Butler P E M. Hyperhidrosis: a review of current management. Plast Reconstr Surg 2002;110:222-228. (Pubitemid 34686276)
25. Rompel R, Scholz S. Subcutaneous curettage vs. injection of botulinum toxin A for treatment of axillary hyperhidrosis. J Eur Acad Dermatol Venereol 2001;15:207-211. (Pubitemid 32898861)
26. Vorkamp T, Foo F, Khan S, et al. Hyperhidrosis: evolving concepts and a comprehensive review. Surgeon 2010;8:287-292.
27. Minor V. Ein neues Verfahren zu der klinischen Untersuchung der Schweissabsonderung. Deutche Zeitung Fürr Nervenheilkunde 1928;101:302-308.
28. Heckmann M, Plewig G. Low-dose efficacy of botulinum toxin A for axillary hyperhidrosis: a randomized, side-byside, open-label study. Arch Dermatol 2005;141:1255-1259. (Pubitemid 41498923)
29. Finlay AY. Quality of life measurement in dermatology: a practical guide. Br J Dermatol 1997;136:305e14.
30. Kowalski JW, Eadie N, Daggett S, et al. Validity and reliability of the Hyperhidrosis Disease Severity Scale (HDSS). Poster presented at the 62nd Annual Meeting of the American Academy of Dermatology; February 6-10, 2004; Washington, DC. Poster P198.
31. Bouman H. The treatment of hyperhidrosis of hands and feet with constant current. Am J Phys Med 1952;31:158-169.
32. Kreyden OP, Scheidegger EP. Anatomy of the sweat glands, pharmacology of botulinum toxin, and distinctive syndromes associated with hyperhidrosis. Clinic Derm 2004;22:40-44. (Pubitemid 38670103)
33. Farrugia MK, Nicholls EA. Intradermal botulinum A toxin injection for axillary hyperhidrosis. J Pediatr Surg 2005;40:1668-1669. (Pubitemid 41530137)
34. Brashear, A, Lew MF, Dykstar DD, et al. Safety and efficacy of Neurobloc (botulinum toxin type B) in type-A-responsive cervical dystonia. Neurology 1999;53:1439-1446. (Pubitemid 29491934)
35. Güleç AT. Dilution of botulinum toxin A in lidocaine vs. in normal saline for the treatment of primary axillary hyperhidrosis: a double-blind, randomized, comparative preliminary study. J Eur Acad Dermatol Venereol 2011 Apr. 15. [Epub ahead of print]
36. Baumann L, Frankel S, Welsh E, Halem M. Cryoanalgesia with dichlorotetrafluoroethane lessens the pain of botulinum toxin injections for the treatment of palmar hyperhidrosis. Dermatol Surg 2003;29:1057e9.
37. Benohanian A. Needle-free anaesthesia prior to botulinum toxin type A injection treatment of palmar and plantar hyperhidrosis. Br J Dermatol 2007;156:593-596.
38. Smith K. Ice minimizes discomfort associated with injection of botulinum toxin type A for the treatment of palmar and plantar hyperhidrosis. Dermatol Surg 2007;33:S88-S91. (Pubitemid 46051405)
39. Solomon BA, Hayman R. Botulinum toxin type A therapy for palmar and digital hyperhidrosis. J Am Acad Dermatol 2000;42:1026-1029. (Pubitemid 30368673)
40. Glaser DA, Hebert AA, Pariser DM, et al. Palmar and plantar hyperhidrosis: best practice recommendations and special considerations. Cutis 2007;79(suppl 5):18-28.
41. Naumann M, Lowe NJ, Kumar CR, et al. Botulinum toxin type A is a safe and effective treatment for axillary hyperhidrosis over 16 months: a prospective study. Arch Dermatol 2003;139:731-736. (Pubitemid 36705939)
42. Boni R, Kreyden OP, Burg G. Revival of the use of botulinum toxin: application in dermatology. Dermatology 2000;200:287-291. (Pubitemid 30451574)